Published Date: 10 Mar 2023
This decision will ensure that effective drugs are available in all communities, and state pharmacies must:
Read Full NewsDr Wilkoff wonders what the effects will be of 12 states proposing changes to restricted foods under SNAP.
The Trump administration is considering appointing Houman Hemmati, an ophthalmologist and a frequent Fox News guest, to lead the FDA's Center for Biologics Evaluation and...
Medical residents report limited structured training in AI and digital health despite increasing clinical relevance.
Reusable catheter strategies may be as safe as single-use devices for preventing UTIs, but questions remain about their practical use.
New research suggests the loss of the corneal reflex — a classic marker of brain death — could help clinicians make more specific assessments during the final days and hours of life.
Taking three doses of ibuprofen before the insertion of an intrauterine device reduces pain during the procedure compared with a placebo.
A study of nine AI chatbots found hallucination rates from 0% to 34%, with Grok 3 performing the worst and Perplexity Research being most reliable.
1.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
2.
CAR T cells improve patients' quality of life: a study
3.
New policy review highlights the importance of health-related quality of life in advanced cancer
4.
EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk
5.
From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study
1.
The latest research on Thyroid Cancer: Symptoms, Diagnosis, and Treatment Options
2.
Cancer Rates on the Rise: What Can We Do to Stop It?
3.
Exploring The Causes and Consequences of Low Transferrin Saturation
4.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
5.
The Unseen Threat: Uncovering the Risks of Pancoast Tumor
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation